Additionally, increased levels of cleaved caspase-3, caspase-8, and caspase-9 and apoptotic bodies were observed in ESCC cells following CMSP treatment (Fig. 1C and Fig. S1C). This evidence concerns the gene CASP9 and esophageal squamous cell carcinoma.